Corona Remedies Limited IPO (CORONA)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Corona Remedies Limited IPO?
The Corona Remedies Limited IPO price band is Rs.1008 to Rs.1062 per share.
When does the Corona Remedies Limited IPO open and close?
Bidding opens 8 December 2025 and closes 10 December 2025.
Is the Corona Remedies Limited IPO a mainboard or SME issue?
Corona Remedies Limited is a mainboard IPO, listing on NSE's main board.
When did the Corona Remedies Limited IPO list?
Corona Remedies Limited listed on 15 December 2025.
Does this page show the grey market premium (GMP) for Corona Remedies Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Corona Remedies Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.